<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 27, 1999
DOCUMENTUM, INC.
(exact name of registrant as specified in its charter)
0-27358
(Commission file number)
Delaware 95-4261421
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
6801 Koll Center Parkway, Pleasanton, California
(Address of principal executive offices)
94566-3145
(Zip Code)
(Registrant's telephone number, including area code): (925) 600-6800
(Former Name or Former Address, if Changed Since Last Report):
5671 Gibraltar Drive, Pleasanton, California, 94588-8547
<PAGE>
Item 4. Changes in Registrant's Certifying Accountants
(a) Previous Independent Accountants.
(i) On September 27, 1999, PricewaterhouseCoopers L.L.P.
resigned as the independent public accountants of
Documentum, Inc. (the "Company").
(ii) The reports of PricewaterhouseCoopers L.L.P. on the
financial statements of the Company for each of the past
two fiscal years contained no adverse opinion or
disclaimer of opinion and were not qualified or modified
as to uncertainty, audit scope or accounting principles.
(iii) The resignation of PricewaterhouseCoopers L.L.P. as the
independent public accountants of the Company was approved
by the Company's audit committee.
(iv) During the Company's two most recent fiscal years and
through September 27, 1999, the Company has had no
disagreements with PricewaterhouseCoopers L.L.P. on any
matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure,
which disagreements if not resolved to the satisfaction of
PricewaterhouseCoopers L.L.P. would have caused it to make
reference to the subject matter of the disagreement in its
report on the financial statements of the Company for such
years.
(v) During the Company's two most recent years and through
September 27, 1999, the Company has had no reportable
events (as defined in Item 304 (a)(1)(v) of Regulation
S-K).
(vi) The Company has provided PricewaterhouseCoopers L.L.P.
with a copy of the disclosures contained in the report and
requested that PricewaterhouseCoopers L.L.P. furnish the
Company with a letter addressed to the Securities and
Exchange Commission stating whether or not it agrees with
the statements made in subsections (i), (ii), (iv) and (v)
above. A copy of such letter, dated September 28, 1999, is
filed as Exhibit 16.1 to this form 8-K.
Item 5. Other Events
On September 29, 1999, Documentum, Inc. announced a strategic global
alliance with PricewaterhouseCoopers L.L.P.
Item 7. Exhibits
Exhibit No. Description
----------- -----------
16.1 Letter from PricewaterhouseCoopers L.L.P. dated
September 28, 1999.
99.1 Documentum, Inc. press release dated September 29,
1999.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant
has duly caused this report on Form 8-K to be signed on its behalf by the
undersigned, thereunto duly authorized.
DOCUMENTUM, INC.
(Registrant)
Date: October 1, 1999 By: /s/ Mark S. Garrett
-----------------------
Mark S. Garrett
Vice President, and Chief Financial Officer
(Duly Authorized Officer and Principal Financial
Officer)
-3-
<PAGE>
EXHIBIT INDEX
Exhibit No. Description of Document
- ----------- -----------------------
16.1 Letter from PricewaterhouseCoopers L.L.P. dated September 28,
1999.
99.1 Documentum, Inc. press release dated September 29, 1999.
-4-
<PAGE>
Exhibit 16.1
[LETTERHEAD OF PRICEWATERHOUSECOOPERS L.L.P.]
September 28, 1999
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read the statements made by Documentum, Inc. (copy attached), which
we understand will be filed with the Commission, pursuant to Item 4 of Form 8-K,
as part of the Company's Form 8-K report dated September 27, 1999. We agree with
the statements concerning our Firm in such 8-K.
Very truly yours,
/s/ PricewaterhouseCoopers L.L.P.
-----------------------------
PricewaterhouseCoopers L.L.P.
<PAGE>
Exhibit 99.1
For Immediate Release
PRICEWATERCOOPERS LLP AND DOCUMENTUM FORGE STRATEGIC
GLOBAL ALLIANCE
PLEASANTON, Calif. -- September 29, 1999 -- Documentum, Inc. (NASDAQ: DCTM), and
PricewaterhouseCoopers have forged a strategic global alliance to develop, sell
and deliver a pre-eminent solution for managing manufacturing documents in the
highly regulated pharmaceutical industry environment.
The venture addresses the substantial market need for a complete, scalable and
flexible content management1 enterprise architecture not currently offered by a
single software and consulting team.
Through their years of experience in defining, delivering and managing
manufacturing implementations, PricewaterhouseCoopers and DOCUMENTUM understand
the immediate challenges pharmaceutical companies can surmount by effectively
managing hundreds of thousands of regulatory documents on a global basis.
Although it is a high priority for companies, in most cases this management is
still performed manually. Regulatory document management costs typically
represent 10 to 15 percent of a pharmaceutical or healthcare product
manufacturing facility's annual costs. More importantly, the ability to
coordinate compliance-critical documents between new product development and
production launch sites during the new product introduction process can decrease
time-to-market by months and create significant new revenue gains.
The unrivalled combination of DOCUMENTUM's Internet-scalable content management
solutions with PricewaterhouseCoopers's deep pharmaceutical industry knowledge,
process and technology consulting experience will provide leading drug
manufacturers with a single source for their complete compliance engineering
needs. These combined efforts will help customers accelerate the new product
introduction process, reduce operational costs and improve compliance
effectiveness everywhere in the world.
"PricewaterhouseCoopers and DOCUMENTUM will pioneer an innovative solution to
replace error-prone manual systems across the enterprise that will immediately
benefit global pharmaceutical companies," said Thomas Heydler, vice president
and general manager of the Applications Business Unit at DOCUMENTUM, Inc.
"PricewaterhouseCoopers' selection of DOCUMENTUM as a cornerstone of its
pharmaceutical practice is testament to our industry-leading technology. Their
global implementation capabilities and vertical industry acumen, coupled with
their e-business approach made them the natural choice for this strategic
relationship."
Both DOCUMENTUM and PricewaterhouseCoopers are making significant contributions
to ensure the new venture's success:
PricewaterhouseCoopers and DOCUMENTUM will devote senior-level industry,
compliance, and technology consultants to co-develop DOCUMENTUM's Internet-
scalable, industry specific content management solutions. These consultants
will be co-located at DOCUMENTUM's Pleasanton, Calif. headquarters.
PricewaterhouseCoopers has formed a major global implementation network with
Centers of Excellence across North America, Europe and Japan that can draw
from a
<PAGE>
team of 5000 consultants with pharmaceutical industry, DOCUMENTUM, and
systems integration expertise. These highly trained consultants will
complement the existing team from DOCUMENTUM.
"DOCUMENTUM is a premier provider of Internet-scale content management software.
PricewaterhouseCoopers welcomes the opportunity to build a major global practice
around DOCUMENTUM, and together we are poised to establish breakaway e-business
solutions for the pharmaceutical industry," said Fergus Byrne, global
pharmaceutical consulting leader, PricewaterhouseCoopers.
PricewaterhouseCoopers has defined several customized and packaged services that
will help customers implement, migrate, configure and validate the solution,
which they plan to demonstrate at their showcase Zone facility in Philadelphia.
In addition, the strategic alliance includes plans to expand beyond
manufacturing documentation to address other key e-business solution areas in
the value chain, such as R&D, and sales and marketing in pharmaceuticals, and
also into other vertical market segments.
Notes to editors:
1 As defined by the market, content management is the information contribution,
collaboration and control that allows organizations to dynamically create and
reuse documents, manuals, publications, and Web pages. The term "content"
encompasses text, images, applets, graphics and multimedia, such as video, audio
and animation.
About DOCUMENTUM
DOCUMENTUM, Inc. is the leading provider of content management solutions that
accelerate innovation and shorten time-to-revenue. Nearly 700 global
corporations rely on DOCUMENTUM to speed the development and marketing of new
products and services that grow the top-line. DOCUMENTUM fuels applications with
the trusted, personalized content required in e-business interactions that lead
to the point of purchase. Tailored to specific vertical markets, the DOCUMENTUM
offering includes its best-in-class content management technology, the
DOCUMENTUM 4i platform, and a family of Web applications to support
collaboration, innovation and e-business. Headquartered in Pleasanton, Calif.,
DOCUMENTUM software and services are sold through a direct sales force, systems
integrators and affiliated distributors worldwide. Additional information is
available at www.documentum.com.
Since 1993, DOCUMENTUM has helped accelerate the new drug application process,
allowing the world's largest pharmaceutical companies to speed new products to
global markets and capture millions of dollars in new revenues. With more than
80 major installations in the pharmaceutical industry today, DOCUMENTUM's proven
technology successfully manages the generation and delivery of high quality
information from research and development through to commercialization and
production in a secure e-business environment.
About PricewaterhouseCoopers
The PricewaterhouseCoopers pharmaceutical practice (www.pwcglobal.com/pharma/)
comprises a full spectrum of international professional experience developed
over many years working with leading pharmaceutical companies. We believe it is
our detailed understanding of the issues confronting the industry that
differentiates us, adding value to our client's business. The sector team
includes over 2,000 industry, functional and technical specialists who are
highly experienced in delivering creative ideas and practical solutions to our
clients. In many countries we are positioned as policy advisers, and participate
in industry forums and associations worldwide.
<PAGE>
The Management Consulting Services practice of PricewaterhouseCoopers helps
clients maximize their business performance by integrating strategic change,
process improvements and technology solutions. Through a worldwide network of
skills and resources, consultants manage complex projects with global
capabilities and local knowledge, from strategy through implementation.
PricewaterhouseCoopers (www.pwcglobal.com) is the world's largest professional
services organization. Drawing on the knowledge and skills of 150,000 people in
150 countries, we help our clients solve complex business problems and
measurably enhance their ability to build value, manage risk and improve
performance.
PricewaterhouseCoopers refers to the US firm of PricewaterhouseCoopers LLP and
other members of the worldwide PricewaterhouseCoopers organization.
Documentum is a trademark of Documentum, Inc. in the U.S. and other countries.
All other company and product names are used for identification purposes only
and may be trademarks of their respective owners.
